Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 22, 2022

View Archived Issues

LCDR regulates lysosomal function through stabilization of LAPTM5 and promotes cancer cell survival

CC40.8 antibody confers protection against SARS-CoV-2 infection

New curcumin derivatives show activity against non-small lung cancer

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Betta Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Discovery of KP-1, an antifibrotic peptide that ameliorates renal fibrosis in vivo

Chinese investigators identify Toll-like receptor antagonists

Apotex patents new antiviral compounds

Shaanxi Synthetic Pharmaceutical presents new thiobenzopyran compounds

Novel Hsp90/HDAC dual inhibitor shows antifungal activity against azole-resistant Candida albicans

RosVivo signs material transfer agreement with Lilly for RSVI-301 for diabetes

Researchers present in vitro data for GYS1 inhibitor MZE-001 in Pompe disease

APTA-1 shows promising biological effects in a coronavirus-induced acute lung injury model

Grant supports Emergex's development of synthetic T-cell vaccine candidate for Chikungunya virus

BioNTech and Medigene collaborate to develop TCR-based immunotherapies for cancer

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Engineered Wnt ligands repair BBB in neuro disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...